These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21325349)

  • 1. Iron and vascular calcification. Is there a link?
    Neven E; De Schutter TM; Behets GJ; Gupta A; D'Haese PC
    Nephrol Dial Transplant; 2011 Apr; 26(4):1137-45. PubMed ID: 21325349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular calcification and ESRD: a hard target.
    Bhan I; Thadhani R
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S102-5. PubMed ID: 19995990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How do we need to maintain the iron status in dialyzed patients treated with erythropoesis stimulating agents].
    Kes P; Basić-Jukići N; Jurić I
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():54-61. PubMed ID: 20232552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Principles of iron therapy in hemodialysis patients].
    Basić-Jukić N; Kes P; Jurić I
    Acta Med Croatica; 2006 Dec; 60(5):457-62. PubMed ID: 17217102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R
    J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular calcification and disordered mineral metabolism in dialysis patients.
    Kalpakian MA; Mehrotra R
    Semin Dial; 2007; 20(2):139-43. PubMed ID: 17374088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular calcification in chronic haemodialysis patients.
    Susalit E
    Acta Med Indones; 2008 Oct; 40(4):177. PubMed ID: 19530366
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjusting i.v. iron and EPO doses in patients on hemodialysis prior to continuing surgery: can we protect our patients education from iron-deficiency anemia?
    Deaver K; Bennington L
    Nephrol Nurs J; 2006; 33(4):430-7; quiz 438. PubMed ID: 17002001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vitamin D, cardiovascular disease and mortality in patients with kidney disease].
    Hansen D; Brandi L; Rasmussen K
    Ugeskr Laeger; 2009 Dec; 171(50):3684-9. PubMed ID: 20003863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of conjunctival and corneal calcification with vascular calcification in dialysis patients.
    Seyahi N; Altiparmak MR; Kahveci A; Yetik H; Kanberoglu K; Serdengecti K; Ataman R; Erek E
    Am J Kidney Dis; 2005 Mar; 45(3):550-6. PubMed ID: 15754277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular calcification in dialysis patients: pathogenesis and consequences.
    Reslerova M; Moe SM
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S96-9. PubMed ID: 12612962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal or individual screening for vascular calcification?
    Karohl C; Raggi P
    Semin Dial; 2011; 24(1):33-4. PubMed ID: 21338390
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous iron therapy in renal failure: friend and foe?
    Afzali B; Goldsmith DJ
    J Nephrol; 2004; 17(4):487-95. PubMed ID: 15372409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts of anemia management in chronic renal failure: impact of NKF-DOQI.
    Eschbach JW
    Semin Nephrol; 2000 Jul; 20(4):320-9. PubMed ID: 10928333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hepcidin in iron homeostasis and anemia in hemodialysis patients.
    Eleftheriadis T; Liakopoulos V; Antoniadi G; Kartsios C; Stefanidis I
    Semin Dial; 2009; 22(1):70-7. PubMed ID: 19250447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vascular calcification in hemodialysis patients].
    Shioi A
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():343-7. PubMed ID: 15250321
    [No Abstract]   [Full Text] [Related]  

  • 18. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
    Ishimura E; Okuno S; Taniwaki H; Kizu A; Tsuchida T; Shioi A; Shoji T; Tabata T; Inaba M; Nishizawa Y
    Kidney Blood Press Res; 2008; 31(1):10-5. PubMed ID: 18097148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous iron, inflammation, and oxidative stress: is iron a friend or an enemy of uremic patients?
    Garneata L
    J Ren Nutr; 2008 Jan; 18(1):40-5. PubMed ID: 18089442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular calcification in patients with end-stage renal disease.
    Pecovnik-Balon B
    Ther Apher Dial; 2005 Jun; 9(3):208-10. PubMed ID: 15966990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.